Cryopyrin Associated Periodic Syndrome

Explore clinical trials studying Cryopyrin Associated Periodic Syndrome. Study availability and eligibility vary by location and protocol.

7 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Cryopyrin Associated Periodic Syndrome trial results

Recruiting

Circadian Rhythm Deregulation in Patients With CAPS

NCT06544018

Conditions: CINCA Syndrome, Chronic Disease, Chronic Inducible Urticaria, +20 more
Locations: Hôpital Femme-Mère-Enfant (HCL) Bron, France

Hôpital Claude Huriez (CHU de Lille) Lille, France

Hôpital de la Croix-Rousse (HCL) Lyon, France

Hôpital Edouard Herriot (HCL) Lyon, France

View Trial Details

Not Yet Recruiting

Are Mast Cells Involved in Autoinflammatory Diseases

NCT05292768

Conditions: Autoinflammatory Disease, Chronic Disease, Chronic Inducible Urticaria, +24 more
Locations: Service de Médecine Interne Paris, France

View Trial Details

Completed

A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome

NCT05812781

Conditions: Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +17 more
Locations: Local Site # 222 San Diego, California, United States

Local Site # 223 Columbus, Georgia, United States

View Trial Details

Completed

Adult Outcomes of Children With CAPS

NCT04856540

Conditions: Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +17 more
Locations: Hop Claude Huriez Chu Lille Lille, France

View Trial Details

Completed

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)

NCT05186051

Conditions: Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +17 more
Locations: Department of Clinical Immunology and Allergy Adelaide, Australia

View Trial Details

Completed

Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334

NCT04086602

Conditions: Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +18 more
Locations: Nucleus Network Melbourne, Victoria, Australia

View Trial Details

Completed

The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada

NCT01105507

Conditions: Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +17 more
Locations: Alberta Children's Hospital, Department of Pediatrics Calgary, Canada

Queen Elizabeth II Hospital Halifax, Canada

View Trial Details

Cryopyrin Associated Periodic Syndrome

Cryopyrin Associated Periodic Syndrome trial results

Circadian Rhythm Deregulation in Patients With CAPS

Are Mast Cells Involved in Autoinflammatory Diseases

A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome

Adult Outcomes of Children With CAPS

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)

Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334

The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada

Related conditions